Evidence map›Paper›PMID 42573673›Full record

ArticleJournal of endocrinological investigation2026

OCT4 modulates Pomc gene transcription by interfering with specific corticotroph transcription factors.

Florencia Herbstein, Josefina Rosmino, Nicolás Budnik, Sergio Senin, Cora Pollak, Alejandra Attorresi, Carolina Perez-Castro, Silvina Figurelli, Mirtha Guitelman, Eduardo Arzt and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of endocrinological investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Florencia Herbstein *Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA), CONICET - Partner Institute of the Max Planck Society, Buenos Aires, C1425FQD, Argentina.ORCID http://orcid.org/0000-0002-2812-3083
Josefina RosminoInstituto de Investigación en Biomedicina de Buenos Aires (IBioBA), CONICET - Partner Institute of the Max Planck Society, Buenos Aires, C1425FQD, Argentina.ORCID http://orcid.org/0000-0002-6645-2507
Nicolás BudnikInstituto de Investigación en Biomedicina de Buenos Aires (IBioBA), CONICET - Partner Institute of the Max Planck Society, Buenos Aires, C1425FQD, Argentina.ORCID http://orcid.org/0009-0002-9629-8958
Sergio SeninInstituto de Investigación en Biomedicina de Buenos Aires (IBioBA), CONICET - Partner Institute of the Max Planck Society, Buenos Aires, C1425FQD, Argentina.
Cora PollakInstituto de Investigación en Biomedicina de Buenos Aires (IBioBA), CONICET - Partner Institute of the Max Planck Society, Buenos Aires, C1425FQD, Argentina.ORCID http://orcid.org/0009-0000-4540-9393
Alejandra AttorresiInstituto de Investigación en Biomedicina de Buenos Aires (IBioBA), CONICET - Partner Institute of the Max Planck Society, Buenos Aires, C1425FQD, Argentina.ORCID http://orcid.org/0009-0005-3560-217X
Carolina Perez-CastroInstituto de Investigación en Biomedicina de Buenos Aires (IBioBA), CONICET - Partner Institute of the Max Planck Society, Buenos Aires, C1425FQD, Argentina.ORCID http://orcid.org/0000-0001-8792-7383
Silvina FigurelliServicio de Patología, Hospital General de Agudos Juan A. Fernández, Buenos Aires, C1425AGP, Argentina.
Mirtha GuitelmanDivisión Endocrinología, Hospital General de Agudos "Carlos G. Durand", Buenos Aires, C1405DCS, Argentina.ORCID http://orcid.org/0000-0002-0245-5346
Eduardo ArztInstituto de Investigación en Biomedicina de Buenos Aires (IBioBA), CONICET - Partner Institute of the Max Planck Society, Buenos Aires, C1425FQD, Argentina.ORCID http://orcid.org/0000-0002-7697-8107
Mariana FuertesInstituto de Investigación en Biomedicina de Buenos Aires (IBioBA), CONICET - Partner Institute of the Max Planck Society, Buenos Aires, C1425FQD, Argentina. mfuertes@ibioba-mpsp-conicet.gov.ar.ORCID http://orcid.org/0000-0002-3015-9560

Funding

Agencia Nacional de Promoción Científica y Tecnológica PICT-2020-01735Agencia Nacional de Promoción Científica y Tecnológica PICT-2021-00262Agencia Nacional de Promoción Científica y Tecnológica PID-CLINICO-2014-0024Consejo Nacional de Investigaciones Científicas y Técnicas PIBAA-0079Consejo Nacional de Investigaciones Científicas y Técnicas PUE-2016-22920160100010COFondo para la Convergencia Estructural del MERCOSUR COF 03/11Fundación Florencio Fiorini 2021-SI196Universidad de Buenos Aires 20020170100230BA
6 · The paper itself

Abstract

backgroundCorticotroph cells produce and secrete adrenocorticotropic hormone (ACTH) from the pro-opiomelanocortin (Pomc) gene. Corticotroph function is controlled by hypothalamic signals through the action of corticotrophin-releasing hormone (CRH) through Nur77 nuclear factor and by feedback repression by glucocorticoids (GC) from adrenal gland acting through the glucocorticoid receptor (GR). Corticotroph adenomas, a pituitary neoplasm, exhibit multiple potential sites of altered signaling, with regulation of the Pomc gene being particularly critical. During differentiation, stem cell markers are silenced, however, some pituitary tumors present expression of progenitor factors. Although some reports show the expression of OCT4 in corticotrophs, its function remains unknow.

methodsWe performed immunoblotting, subcellular fractionation and histochemistry to determine the protein expression of OCT4 in corticothoph cells and in corticotrophic human samples. To study the transcriptional modulation of Pomc promoter by OCT4 and the mechanistic interaction between knowing regulators of ACTH-secreting cells and OCT4, we performed luciferase reporter and immunoprecipitation assays.

resultsOCT4 is expressed in AtT-20 corticotroph cells, in human tumoral samples of patients with an ACTH-secreting tumor, and to a much lesser extent in normal pituitary, showing an expression predominantly nuclear. OCT4 inhibits the transcription of the Pomc gene not by binding to the Pomc promoter, but through its interaction with the transcription factor Nur77. OCT4 also interacts with the negative Pomc regulator GR.

conclusionOur study allows to identify that progenitor marker OCT4 is not only expressed in corticotroph pituitary cells but acts on Pomc regulation through the functional interaction with Nur77 and GR.

Indexed as

CorticotrophGRNur77OCT4Pomc

Identifiers

PMID42573673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.